(Q40605284)

22 September 2017

Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses (English)

1 reference

22 September 2017

1 reference

1 reference

3

1 reference

22 September 2017

Seong YR

1

1 reference

22 September 2017

Choi S

2

1 reference

22 September 2017

Lee CH

4

1 reference

22 September 2017

Lee CK

5

1 reference

22 September 2017

Im DS

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

22 September 2017

1 reference

22 September 2017

19

1 reference

22 September 2017

20-22

1 reference

22 September 2017

2955-2964

1 reference

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Vaccinia virus: a tool for research and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Genetic organization and diversity of the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Molecular virology of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Biosynthesis and biochemical properties of the hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Characterization of the structural proteins of hepatitis C virus expressed by an adenovirus recombinant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Binding of hepatitis C virus to CD81

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Recombinant adenoviruses as vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Methods for construction of adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Overexpression and simple purification of a truncated, immunologically reactive GST-HCV core (1-123) fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Hepatitis C virus structural proteins assemble into viruslike particles in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Structure-function analysis of hepatitis C virus envelope-CD81 binding

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Cellular immune response to the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900534-X

7 January 2021

10.1016/S0264-410X(00)00534-X

Identifiers

DOI

1 reference

22 September 2017

1 reference